Why is Fortis Health. falling/rising?

As of 28-Jul, Fortis Healthcare Ltd is currently priced at 842.00, reflecting a decrease of 3.25 points or 0.38%. Despite this recent decline, the stock has shown strong performance over the past week and month, with returns of 4.90% and 7.48%, respectively. It recently hit a new 52-week high of Rs. 854.5, indicating strong upward momentum prior to the current dip. The stock has been outperforming its sector by 0.57% today, although it has experienced a consecutive fall over the last two days, resulting in a total decline of 0.65% during this period. Fortis Healthcare benefits from a low Debt to EBITDA ratio of 1.15 times, a healthy annual operating profit growth rate of 30.49%, and high institutional holdings at 56.97%, which contribute to its stability and attractiveness to investors.
In the broader market context, Fortis Healthcare has significantly outperformed the Sensex, which has declined by 1.59% over the past week, while Fortis has risen. This trend is further supported by the stock's impressive long-term returns, including a 65.07% increase over the past year and a remarkable 204.30% rise over the last three years, consistently outperforming the BSE500. The stock's liquidity is also favorable, with a delivery volume increase of 15.65% against the 5-day average, indicating rising investor participation. Despite the recent price drop, the overall performance metrics suggest a strong underlying demand for the stock, reflecting confidence in its future growth potential.